CHI's Structure-Based Drug Design conference will feature comprehensive sessions covering: structure-based modeling of GPCRs, determination of protein-protein interaction sites, computational based protein design, hit and lead optimization, accounting for receptor flexibility in ligand binding, challenges of docking and screening, experimental approaches, and case studies.